The Combined Prognostic Potential of Serum High-Sensitivity Cardiac Troponin I and N-Terminal pro-B-Type Natriuretic Peptide Concentrations in Dogs with Degenerative Mitral Valve Disease
Open Access
- 28 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 26 (2) , 302-311
Abstract
Background Identification of factors associated with decreased survival in dogs with degenerative mitral valve disease (DMVD) will allow more accurate prognosis. N-terminal pro-B-type natriuretic peptide (NT-proBNP) is negatively associated with survival in dogs with DMVD. In human patients, multimarker strategies provide superior risk stratification compared with single markers. Hypothesis High-sensitivity cardiac troponin I (hscTnI) and other clinical variables will be associated with survival time in dogs with DMVD. Measuring hscTnI and NT-proBNP in combination will be prognostically superior to measurement of either marker alone. The rate of change of these markers will vary according to cause of death. Animals Client-owned dogs (n = 202) with DMVD of varying severity and age-matched healthy control dogs (n = 30) recruited from first opinion private practice. Methods Prospective cohort study relating clinical variables at enrollment in dogs with DMVD to survival time (all-cause, cardiac, and noncardiac mortality). Multivariable Cox regression analysis was used to identify factors associated with survival. Measurements were obtained approximately every 6 months. Repeated measures models were constructed to assess changes over time. Results hscTnI, LVEDDN, heart rate, and age were independently associated with decreased survival time (all-cause mortality). Survival times were shortest in dogs in which both serum hscTnI and NT-proBNP were increased. hscTnI and NT-proBNP increased more rapidly in dogs that died of cardiac disease. Conclusions and Clinical Importance Serum hscTnI has prognostic value in dogs with DMVD. Measurement of NT-proBNP and hscTnI is prognostically superior to measuring either alone. Serial measurement strategies provide additional prognostic information.Keywords
Funding Information
- Petplan Charitable Trust
- Idexx Ltd
This publication has 21 references indexed in Scilit:
- Serum cardiac troponin I in dogs with primary immune-mediated haemolytic anaemiaJournal of Small Animal Practice, 2011
- Mortality in North American Dogs from 1984 to 2004: An Investigation into Age-, Size-, and Breed-Related Causes of DeathJournal of Veterinary Internal Medicine, 2011
- Association of Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration with Mitral Regurgitation Severity and Outcome in Dogs with Asymptomatic Degenerative Mitral Valve DiseaseJournal of Veterinary Internal Medicine, 2009
- Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve DiseaseJournal of Veterinary Internal Medicine, 2008
- Natriuretic PeptidesJACC, 2007
- The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac diseaseJournal of Small Animal Practice, 2007
- Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart FailureCirculation, 2007
- Serum concentrations of cardiac troponin I and cardiac troponin T in dogs with class IV congestive heart failure due to mitral valve diseaseJournal of Veterinary Emergency and Critical Care, 2007
- Cardiac troponin I levels in canine pyometraActa Veterinaria Scandinavica, 2007
- THE PREVALENCE AND TYPES OF CARDIOVASCULAR DISEASE IN DOGS*Annals of the New York Academy of Sciences, 1965